NASDAQ · Drug Manufacturers - Specialty & Generic

QNTM (QNTM) Stock

$2.96 +2.35% NASDAQ: QNTM Healthcare

Valuation

MetricValue
Price$2.96
Market Cap$18.93M
P/E Ratio-0.60
P/B Ratio3.13
P/S Ratio0.00
EPS (TTM)$-8.11
52-Week High$32.58
52-Week Low$2.07
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-371.43%
ROA-236.36%
ROCE-300.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity1.46
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-34.0M$-27.0M$-24.0M$-16.0M$-15.0M
Net Profit$-35.0M$-24.0M$-18.0M$-14.0M$-26.0M
EPS$-65.63$-39.62$-29.39$-12.49$-8.11
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$63.0M$38.0M$17.0M$17.0M$11.0M
Total Liabilities$9.0M$8.0M$5.0M$7.0M$6.0M
Cash$35.0M$17.0M$3.0M$6.0M$2.0M
Borrowings$1.0M$1.0M$0$1.0M$2.0M

Latest News

Quantum BioPharma (QNTM) Developing Two-Pronged Attack on Brain Disorders Affecting Millions NewMediaWire · Jul 22, 2026 Quantum BioPharma Plans to Settle Debt MT Newswires · Jul 21, 2026 Quantum BioPharma Announces Intention to Settle Debt GlobeNewswire · Jul 20, 2026 Quantum BioPharma (QNTM) Expands Clinical Development of Neuroprotective Therapy NewMediaWire · Jul 15, 2026 Why Quantum BioPharma (QNTM) Is 'One to Watch' NewMediaWire · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-21.0M$-28.0M$-11.0M$-7.0M$-8.0M
Investing Cash Flow$0$12.0M$0$-2.0M$-2.0M
Financing Cash Flow$0$-2.0M$-3.0M$0$0
Net Cash Flow$18.0M$-18.0M$-14.0M$3.0M$-4.0M
Free Cash Flow$-21.0M$-29.0M$-11.0M$-7.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-19.24%
Quick Ratio0.63
Interest Coverage-15.00
Return 1Y-82.39%
Return 3Y-95.53%
Return 5Y-96.63%

Ownership

Insiders Held12.36%
Institutions Held11.46%
Institutions Float Held13.07%
Institutional HolderSharesReport Date
AdvisorShares Investments, LLC108,5912026-03-31
Platform Technology Partners41,1162026-03-31
Jane Street Group, LLC31,5012026-03-31
Citadel Advisors Llc15,8632026-03-31
Marex Group Plc13,4682026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANVS $1.70 +0.59% -1.54 $33.45M 0.00%
ATNM $0.80 +1.32% -1.07 $25.02M 0.00%
BCABBioAtla, Inc. $3.40 +0.89% -0.08 $4.29M 0.00%
CELUCelularity Inc. $0.75 +0.13% -0.20 $21.74M 0.00%
CPIX $6.87 -2.28% -28.95 $102.93M 0.00%

About QNTM

QNTM is led by CEO Zeeshan Saeed, employs 17 people, headquartered in CA, publicly traded since 2018.

QNTM stock trades at $2.96 with a market capitalization of $18.93M. The stock is valued at a price-to-earnings (P/E) ratio of -0.60, price-to-book of 3.13, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $2.07 and $32.58, and currently trades 90.9% below its 52-week high.

On profitability, QNTM generates a return on equity (ROE) of -371.43%, return on capital employed of -300.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides